HIVMA is pleased to announce the election of five members to its Board of Directors and to name Judith Feinberg, MD, FIDSA as its new Chair.
HIVMA is pleased to announce the election of five members to its Board of Directors and to name Judith Feinberg, MD, FIDSA as its new Chair.
Recognizing preeminent contributions to the field of HIV medicine in clinical education and research, HIVMA will present its 2019 Awards for Excellence to Dr. Carlos del Rio, FIDSA, and Dr. Andrea L. Ciaranello, MPH, FIDSA, at IDWeek 2019 events in Washington, DC.
IDSA welcomes the Society of Infectious Diseases Pharmacists as a partner in IDWeek, the premier scientific meeting for infectious diseases professionals. SIDP becomes the fifth partner in IDWeek, joining IDSA, the HIV Medicine Association, the Pediatric Infectious Diseases Society and the Society for Healthcare Epidemiology of America.
New CMS rule requiring hospital antibiotic stewardship programs will enable critical advances toward control of AMR.
As leaders from around the world gather in New York today for the United Nations Secretary-General’s Climate Action Summit, IDSA highlights immediate threats posed by climate change to human health.
Senate spending bills show encouraging recognition of public health threats, but discouraging gaps.
IDSA, HIVMA and the American Academy of HIV Medicine call for antiretroviral treatment stewardship in hospital settings to support appropriate use of the drugs, in a paper published in Clinical Infectious Diseases.
The IDSA Foundation has named Stephen E. Peeler, CFRE, as its executive director. The IDSA Foundation is the charitable arm of The Infectious Diseases Society of America, an 11,000-member society representing ID practitioners throughout the world.
The U.S. Customs and Border Patrol’s decision to withhold vaccinations against seasonal influenza from migrants in border detention facilities is a violation of the most basic principles of public health and human rights.
A CDC report on antibiotics use in health care U.S. healthcare settings show progress made in promoting appropriate use of infection-fighting drugs, but strengthened and continued efforts needed.
A new collection of articles highlighting the science and complexity of inclusion, diversity, access, and equity is now available online, part of an ongoing commitment to drive improvements within the field of infectious diseases and the Infectious Diseases Society of America (IDSA).
The Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR) have extended the public comment period for the draft of their joint guidelines for the prevention, diagnosis, and treatment of Lyme disease for an additional 30 days.